# US 2012/0251600 A1 · Skin compositions and methods of use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251600 A1
- Document ID: US20120251600A1
- Status: Published application
- Kind: A1
- Application number: 13/430,563
- Filed: 2012-03-26
- Published: 2012-10-04
- Earliest claimed: 2010-08-31
- Assignees: Living Proof, Inc.
- Inventors: Betty YU; Joseph LOMAKIN; Soo-Young KANG; Benjamin W. ADAMS
- Web page: https://patentgrep.com/patent/US20120251600A1

## CPC

- A61K 31/765: Polymers containing oxygen
- A61K 8/0204: {Specific forms not provided for by any of groups A61K8/0208 - A61K8/14}
- A61K 8/19: containing inorganic ingredients
- A61K 8/25: Silicon; Compounds thereof
- A61K 8/29: Titanium; Compounds thereof
- A61K 8/345: {containing more than one hydroxy group}
- A61K 8/585: {Organosilicon compounds}
- A61K 8/891: saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K 8/894: modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
- A61K 8/895: containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
- A61L 26/0019: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds}
- A61L 26/0095: {Composite materials, i.e. containing one material dispersed in a matrix of the same or different material}
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61Q 1/02: Preparations containing skin colorants, e.g. pigments (preparations in powder form A61Q1/12)
- A61Q 1/14: Preparations for removing make-up
- A61Q 19/00: Preparations for care of the skin
- A61Q 19/06: for countering cellulitis
- A61Q 19/08: Anti-ageing preparations
- A61K 2800/412: Microsized, i.e. having sizes between 0.1 and 100 microns
- A61K 2800/43: Pigments; Dyes
- A61K 2800/58: Metal complex; Coordination compounds
- A61K 2800/5922: At least two compounds being classified in the same subclass of A61K8/18
- A61K 2800/884: Sequential application
- A61K 2800/95: Involves in-situ formation or cross-linking of polymers
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Provided are body corrective cosmetic formulations and methods of use thereof.

## Claims

### Claim 1

A body corrective formulation for application to the skin, comprising:
a) a reactive reinforcing component; and
b) a cross-linking component;
wherein said cross-linking component facilitates in situ cross-linking of the reactive reinforcing component, such that a body corrective film is formed on skin, and wherein said film when formed has an appearance of natural skin.

### Claim at position 2

-4. (canceled)

### Claim 5 (depends on 1)

The formulation of claim 1, wherein said reactive reinforcing component and said cross-linking component are prevented from contacting each other prior to use.

### Claim 6 (depends on 1)

The formulation of claim 1, wherein said reactive reinforcing component comprises a reactive constituent and a reinforcing constituent.

### Claim 7 (depends on 6)

The formulation of claim 6, wherein said reactive constituent comprises at least one organopolysiloxane and at least one hydride functionalized polysiloxane.

### Claim 8 (depends on 7)

The formulation of claim 7, wherein said organopolysiloxane is a high viscosity organopolysiloxane or a low viscosity organopolysiloxane or a combination thereof.

### Claim at position 7

-10. (canceled)

### Claim 11 (depends on 8)

The formulation of claim 8, wherein said high viscosity organopolysiloxane is substantially vinyl terminated.

### Claim 12 (depends on 8)

The formulation of claim 8, wherein said high viscosity organopolysiloxane is polydimethylsiloxane.

### Claim 13 (depends on 8)

The formulation of claim 8, wherein said high viscosity organopolysiloxane has a weight percent of vinyl of between about 0.05 and about 0.1 or a vinyl equivalent per kilogram of between about 0.001 and about 0.05 or a combination thereof.

### Claim 14

(canceled)

### Claim 15 (depends on 8)

The formulation of claim 8, wherein said low viscosity organopolysiloxane has a viscosity of between about 1,000 and about 50,000 cSt or cP at 25° C.; a weight percent of vinyl of between about 0.01 and about 0.5; or a vinyl equivalent per kilogram of between about 0.001 and about 0.1 or a combination thereof.

### Claim at position 13

-19. (canceled)

### Claim 20 (depends on 8)

The formulation of claim 8, wherein said low viscosity organopolysiloxane is substantially vinyl terminated.

### Claim 21 (depends on 8)

The formulation of claim 8, wherein said low viscosity organopolysiloxane is vinyl terminated polydimethylsiloxane.

### Claim 22 (depends on 7)

The formulation of claim 7, wherein said hydride functionalized polysiloxane has a viscosity of between about 2 and 10,000 cSt or cP at 25° C.; a percent SiH content of between about 5 and about 75%; or a SiH content of between about 0.5 and about 10 mmol/g; or a combination thereof.

### Claim at position 17

-24. (canceled)

### Claim 25 (depends on 7)

The formulation of claim 7, wherein said hydride functionalized polysiloxane is selected from the group consisting of hydride terminated polydimethylsiloxane; polyphenyl-(dimethylhydrosiloxy)siloxane, hydride terminated; methylhydrosiloxane-phenylmethylsiloxane copolymer, hydride terminated; methylhydrosiloxane-dimethylsiloxane copolymers, trimethylsiloxy terminated; polymethylhydrosiloxanes, trimethylsiloxy terminated; polyethylhydrosiloxane, triethylsiloxane, methylhydrosiloxane-phenyloctylmethylsiloxane copolymer; methylhydrosiloxane-phenyloctylmethylsiloxane terpolymer and combinations thereof.

### Claim 26 (depends on 25)

The formulation of claim 25, wherein said hydride functionalized polysiloxane is substantially alkyl terminated.

### Claim 27

(canceled)

### Claim 28 (depends on 7)

The formulation of claim 7, wherein said hydride functionalized polysiloxane has at least 2 Si—H units on average.

### Claim 29

(canceled)

### Claim 30 (depends on 1)

The formulation of claim 1, wherein said reactive reinforcing component has a vinyl organopolysiloxane to functional hydride molar ratio of between about 1:10 and about 1:100.

### Claim at position 24

-32. (canceled)

### Claim 33 (depends on 6)

The formulation of claim 6, wherein said reinforcing constituent is selected from the group consisting of optionally surface treated mica, zinc oxide, titanium dioxide, aluminum oxide, clay or silica.

### Claim at position 26

-40. (canceled)

### Claim 41 (depends on 1)

The formulation of claim 1, wherein the crosslinking component comprises a metal catalyst.

### Claim 42 (depends on 41)

The formulation of claim 41, wherein said catalyst is a platinum catalyst.

### Claim 43 (depends on 42)

The formulation of claim 42, wherein said catalyst is selected from the group consisting of platinum carbonyl cyclovinylmethylsiloxane complexes, platinum divinyltetramethyldisiloxane complexes, platinum cyclovinylmethylsiloxane complexes, platinum octanaldehyde/octanol complexes and combinations thereof.

### Claim at position 30

-46. (canceled)

### Claim 47 (depends on 1)

The formulation of claim 1, wherein said formulation further comprises a cosmetic agent or a therapeutic agent.

### Claim 48

A body corrective film prepared by a process comprising the steps of:
a) applying a reactive reinforcing component to skin; and
b) applying a cross-linking component to said reactive reinforcing component,
wherein said cross-linking component facilitates in situ cross-linking of the reactive reinforcing component, such that a body corrective film is formed on skin.

### Claim at position 33

-50. (canceled)

### Claim 51 (depends on 48)

The film of claim 48, wherein the film has a leather adhesive force of greater than about 20 N/mm; a Young's Modulus of between about 0.01 and about 1 MPa; a fracture strain is at least about 150%; a hysteresis of less than about 5%; or an adhesion of between about 20 N/mm and about 80 N/mm; or a combination thereof.

### Claim at position 35

-55. (canceled)

### Claim 56 (depends on 48)

The film of claim 48, wherein the film is less than about 100 microns thick.

### Claim 57 (depends on 48)

The film of claim 48, wherein the film shrinks by less than about 1 to about 15%.

### Claim 58 (depends on 48)

The film of claim 48, wherein said film upon application to the body has the appearance of natural skin; or provides elasticity and recoil approaching that of youthful skin; or a combination thereof.

### Claim 59

(canceled)

### Claim 60

A method for correcting skin imperfections on a subject's skin comprising applying to said subject's skin a formulation comprising:
a) a first reactive reinforcing component; and
b) a second cross-linking component;
wherein said cross-linking component facilitates in situ cross-linking of the reactive reinforcing component, such that a film is formed on skin, thereby correcting skin imperfections.

### Claim at position 41

-62. (canceled)

### Claim 63

A method of shaping a subject's body, comprising applying to said subject's body a formulation comprising:
a) a first reactive reinforcing component; and
b) a second cross-linking component;
wherein said cross-linking component facilitates in situ cross-linking of the reactive reinforcing component such that a film is formed on body, thereby shaping the body.

### Claim 64 (depends on 63)

The method of claim 63, wherein the film shapes the body by providing support to soft body tissues; or reduces sagging of soft body tissues or a combination thereof.

### Claim at position 44

-66. (canceled)

### Claim 67

A method for delivering an agent to a subject, comprising applying to the subject's skin a formulation comprising:
a) a first reactive reinforcing component optionally comprising one or more agents; and
b) a second cross-linking component optionally comprising one or more agents;
wherein said cross-linking component facilitates in situ cross-linking of the reactive reinforcing component such that a film is formed on skin, thereby delivering the agent to the subject.

### Claim 68

(canceled)

### Claim 69

A body corrective composition for application to a subject's body, comprising at least one preselected function modulating component, wherein said composition forms a body corrective film upon application to the subject's body, and wherein said film has an appearance of natural skin.

### Claim at position 48

-71. (canceled)

### Claim 72

A film removing cleanser comprising a film wetting component, a penetration component, a film swelling component and a film release component

### Claim at position 50

-91. (canceled)

### Claim 92 (depends on 1)

The formulation of claim 1, wherein the formulation further comprises a finishing formulation applied to the film after formation of the film.

### Claim at position 52

-95. (canceled)

### Claim 96 (depends on 1)

The formulation of claims 1 further comprising a pigment dispersion formulation.

### Claim at position 54

-109. (canceled)

### Claim 110

A wrinkle corrective formulation for application to the skin, comprising:
a) a reactive reinforcing component; and
b) a cross-linking component;
wherein said cross-linking component facilitates in situ cross-linking of the reactive reinforcing component, such that a wrinkle corrective film is formed on skin, and wherein said film when formed reduces the appearance of wrinkles.

### Claim 111

A bag reducing formulation for application to the skin, comprising:
a) a reactive reinforcing component; and
b) a cross-linking component;
wherein said cross-linking component facilitates in situ cross-linking of the reactive reinforcing component, such that a bag reducing film is formed on skin, and wherein said film when formed reduces the appearance of bags under the eyes.

### Claim 112

A firmness imparting formulation for application to the skin, comprising:
a) a reactive reinforcing component; and
b) a cross-linking component;
wherein said cross-linking component facilitates in situ cross-linking of the reactive reinforcing component, such that a firmness imparting film is formed on skin, and wherein said film when formed imparts an appearance of firmness to the skin.
